Article Details
Retrieved on: 2024-06-21 21:46:27
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“We are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the US and Canada,” said CEO Stephane Bancel in a statement.
Article found on: guardian.ng
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here